 Clinical experience benzodiazepine antagonist flumazenil suspected benzodiazepine ethanol poisoning clinical efficacy different doses specific benzodiazepine antagonist flumazenil total patients benzodiazepine ethanol randomized double-blind study patients group patients group benzodiazepine mg group mg group flumazenil placebo stage coma heart rate blood pressure respiratory rate min change stage coma mg group mg group flumazenil stage coma heart rate blood pressure similar way effect mg flumazenil patients group patients group ethanol intoxication open trial clinical efficacy flumazenil diagnosis benzodiazepine ethanol overdose patients group patients toxicological screening benzodiazepine ethanol None patients placebo effects stage coma heart rate blood pressure respiratory rate Patients benzodiazepine overdose mg consciousness min end injection effect mg group benzodiazepine-induced coma pronounced patients ethanol overdose group ethanol-induced coma mg flumazenil patients group effect flumazenil ethanol-induced coma group group useful benzodiazepine ethanol intoxication patient coma due flumazenil effective possible analytical interference flumazenil metabolites identification benzodiazepines toxicological screening procedure oral dose mg flumazenil interference immunological benzodiazepine assays EMIT TDX RIA metabolite artifact flumazenil urine gas chromatography/mass spectrometry